{"filing":{"accession_number":"0001193125-26-401239","cik":"0001585608","ticker":"JAGX","company_name":"Jaguar Health, Inc.","form":"8-K","filing_date":"2026-09-24","report_date":"2026-09-23","primary_document":"d130901d8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1585608/000119312526401239/d130901d8k.htm"},"events":[{"id":34977,"run_id":32208,"accession_number":"0001193125-26-401239","anchor_item_number":"3.02","event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.75,"summary":"Jaguar Health completed a debt-for-equity exchange on September 23, 2026, issuing 729,989 shares of common stock (including 182,091 shares under Item 1.01 and 547,898 shares under Item 1.02) to reduce and fully cancel approximately $6.73M in secured promissory note obligations. The transaction materially restructures the company's capital structure through equity dilution.","company_name":"Jaguar Health, Inc.","ticker":"JAGX","filing_date":"2026-09-24","form":"8-K","submitted_at":null,"items":[{"id":38878,"accession_number":"0001193125-26-401239","item_number":"1.01","item_title":null,"event_type":"debt_issuance","event_domain":"financial","is_material":true,"confidence":0.35,"reasoning":"The filing discloses a debt-for-equity exchange on September 23, 2026, where Jaguar Health exchanged 182,091 shares of common stock for a $1,678,320 reduction in the outstanding balance of a secured promissory note. While this involves modification of an existing debt obligation, the core transaction is a restructuring that reduces debt through equity issuance rather than creation of new debt. However, the Item 1.01 classification and the framing as an \"exchange agreement\" suggest this may be better characterized as a dilutive_issuance (equity for debt reduction) or financial_other (debt restructuring). The ambiguity between whether this is primarily a debt modification, an equity issuance, or a capital restructuring creates genuine uncertainty about the best event type.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-25T10:01:44.242679+00:00","company_name":"","ticker":null,"filing_date":""},{"id":38879,"accession_number":"0001193125-26-401239","item_number":"1.02","item_title":null,"event_type":"debt_issuance","event_domain":"financial","is_material":true,"confidence":0.45,"reasoning":"The filing discloses termination of a material debt obligation through an exchange transaction where Jaguar Health issued 547,898 shares to reduce a $5.05M balance on a $10.81M secured promissory note, resulting in full cancellation of the 2025 Note. While the Item 1.02 caption emphasizes \"termination,\" the substance involves a significant debt restructuring and equity issuance that materially affects the capital structure. The classification is uncertain because this could also be characterized as a dilutive equity issuance (Item 3.02) or a debt restructuring event not cleanly fitting the taxonomy.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-25T10:01:44.242679+00:00","company_name":"","ticker":null,"filing_date":""},{"id":38880,"accession_number":"0001193125-26-401239","item_number":"3.02","item_title":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.85,"reasoning":"Item 3.02 discloses an unregistered sale of equity securities — specifically \"2021 Note Exchange Shares\" issued under Section 3(a)(9) of the Securities Act. This is a classic dilutive issuance event. The incorporation by reference to Item 1.01 suggests this is part of a larger transaction (likely a debt-for-equity exchange), which is material to investors assessing capital structure and ownership dilution.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-25T10:01:44.242679+00:00","company_name":"","ticker":null,"filing_date":""}]},{"id":34978,"run_id":32208,"accession_number":"0001193125-26-401239","anchor_item_number":"8.01","event_type":"other_material","event_domain":"catchall","is_material":false,"confidence":0.85,"summary":"Routine disclosure of shares outstanding as of September 24, 2026.","company_name":"Jaguar Health, Inc.","ticker":"JAGX","filing_date":"2026-09-24","form":"8-K","submitted_at":null,"items":[{"id":38881,"accession_number":"0001193125-26-401239","item_number":"8.01","item_title":null,"event_type":"other_material","event_domain":"catchall","is_material":false,"confidence":0.85,"reasoning":"This disclosure is a routine administrative statement of shares outstanding as of a specific date (September 24, 2026). It provides factual information about capitalization but does not announce a material corporate event, transaction, or change in circumstances. Such share-count disclosures are typically included for informational purposes and do not affect a reasonable investor's assessment of the registrant's financial condition or prospects.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-25T10:01:44.242679+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":38878,"accession_number":"0001193125-26-401239","item_number":"1.01","item_title":null,"event_type":"debt_issuance","event_domain":"financial","is_material":true,"confidence":0.35,"reasoning":"The filing discloses a debt-for-equity exchange on September 23, 2026, where Jaguar Health exchanged 182,091 shares of common stock for a $1,678,320 reduction in the outstanding balance of a secured promissory note. While this involves modification of an existing debt obligation, the core transaction is a restructuring that reduces debt through equity issuance rather than creation of new debt. However, the Item 1.01 classification and the framing as an \"exchange agreement\" suggest this may be better characterized as a dilutive_issuance (equity for debt reduction) or financial_other (debt restructuring). The ambiguity between whether this is primarily a debt modification, an equity issuance, or a capital restructuring creates genuine uncertainty about the best event type.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-25T10:01:44.242679+00:00","company_name":"Jaguar Health, Inc.","ticker":"JAGX","filing_date":"2026-09-24"},{"id":38879,"accession_number":"0001193125-26-401239","item_number":"1.02","item_title":null,"event_type":"debt_issuance","event_domain":"financial","is_material":true,"confidence":0.45,"reasoning":"The filing discloses termination of a material debt obligation through an exchange transaction where Jaguar Health issued 547,898 shares to reduce a $5.05M balance on a $10.81M secured promissory note, resulting in full cancellation of the 2025 Note. While the Item 1.02 caption emphasizes \"termination,\" the substance involves a significant debt restructuring and equity issuance that materially affects the capital structure. The classification is uncertain because this could also be characterized as a dilutive equity issuance (Item 3.02) or a debt restructuring event not cleanly fitting the taxonomy.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-25T10:01:44.242679+00:00","company_name":"Jaguar Health, Inc.","ticker":"JAGX","filing_date":"2026-09-24"},{"id":38880,"accession_number":"0001193125-26-401239","item_number":"3.02","item_title":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.85,"reasoning":"Item 3.02 discloses an unregistered sale of equity securities — specifically \"2021 Note Exchange Shares\" issued under Section 3(a)(9) of the Securities Act. This is a classic dilutive issuance event. The incorporation by reference to Item 1.01 suggests this is part of a larger transaction (likely a debt-for-equity exchange), which is material to investors assessing capital structure and ownership dilution.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-25T10:01:44.242679+00:00","company_name":"Jaguar Health, Inc.","ticker":"JAGX","filing_date":"2026-09-24"},{"id":38881,"accession_number":"0001193125-26-401239","item_number":"8.01","item_title":null,"event_type":"other_material","event_domain":"catchall","is_material":false,"confidence":0.85,"reasoning":"This disclosure is a routine administrative statement of shares outstanding as of a specific date (September 24, 2026). It provides factual information about capitalization but does not announce a material corporate event, transaction, or change in circumstances. Such share-count disclosures are typically included for informational purposes and do not affect a reasonable investor's assessment of the registrant's financial condition or prospects.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-25T10:01:44.242679+00:00","company_name":"Jaguar Health, Inc.","ticker":"JAGX","filing_date":"2026-09-24"}]}